Literature DB >> 13058283

H.P.C. (3-hydroxy-2-phenylcinchoninic acid) in rheumatoid arthritis.

L MANDEL, G D KERSLEY.   

Abstract

Entities:  

Keywords:  ARTHRITIS, RHEUMATOID/therapy; CINCHOPHEN/derivatives

Mesh:

Substances:

Year:  1953        PMID: 13058283      PMCID: PMC1030470          DOI: 10.1136/ard.12.2.136

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  3 in total

1.  Protein-binding properties and clinical effects of 3-hydroxy-2-phenylcinchoninic acid.

Authors:  B V JAGER
Journal:  Bull Johns Hopkins Hosp       Date:  1952-02

2.  The anti-rheumatic effects of 3-hydroxy-2-phenylcinchoninic acid (HPC) in gout, rheumatic fever, and rheumatoid arthritis.

Authors:  J SIMSON; J J BUNIM
Journal:  Am J Med Sci       Date:  1951-11       Impact factor: 2.378

3.  Trial of a cinchoninic acid derivative in some collagen diseases.

Authors:  J B RENNIE; J A MILNE; J SOMMERVILLE
Journal:  Br Med J       Date:  1951-02-24
  3 in total
  1 in total

1.  Assessment of therapeutic agents in rheumatoid arthritis.

Authors:  L MANDEL
Journal:  Can Med Assoc J       Date:  1956-04-01       Impact factor: 8.262

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.